SCHEMBL3033729

SCHEMBL3033729

COc1cc(NC(=O)c2ccc3[nH]c(-c4ccc(Cl)c5c4C(=O)NC5)cc3c2)cc(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.46
KDR P35968 3/20 0.46
PLAU P00749 2/20 0.44
PLG P00747 1/20 0.42
RAB9A P51151 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
CDK1 P06493 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3043905 0.87 MAOB (0.45) AURKAKDRMEN1KMT2ATP53
SCHEMBL3042431 0.87 KDR (0.45) AURKAKDRPLAUMEN1KMT2A
SCHEMBL3043663 0.83 NHERF1 (0.46) AURKAKDRPLAUPLGMEN1
SCHEMBL3041856 0.82 PYGL (0.47) AURKAKDRMEN1KMT2AMAOA
SCHEMBL27700328 0.81 PLAU (0.42) PLAUPLGRAB9AMEN1KMT2A
SCHEMBL3047764 0.80 KDR (0.49) AURKAKDRPLAUPLGCDK1
SCHEMBL3041519 0.79 HPGD (0.45) AURKAKDRMEN1KMT2ASMN1; SMN2
SCHEMBL3052832 0.79 NHERF1 (0.47) AURKAKDRPLAUPLGTP53
SCHEMBL3042291 0.79 KDR (0.42) AURKAKDRPLAUPLGMAOA
SCHEMBL3048016 0.78 PARP1 (0.53) AURKAKDRKMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 AURKA 2312/4885KDR 3226/4885PLAU 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.